Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 The meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 11, 2021, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and nine months ended December 31, 2020.In continuation with our earlier notice for the closure of trading window and in accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders and in terms of BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019, the 'Trading Window" (period for trading in Company's securities) has been closed with effect from January 01, 2021 and shall continue to remain closed till 48 hours after declaration of unaudited financial results for the quarter and nine months ended December 31, 2020.
03-02-2021
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Notice Of Board Meeting And Closure Of Trading Window

 Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 11, 2021, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and nine months ended December 31, 2020. The 'Trading Window" (period for trading in Company's securities) has been closed with effect from January 01, 2021 and shall continue to remain closed till 48 hours after declaration of unaudited financial results for the quarter and nine months ended December 31, 2020. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's Equity Shares, either in their own name or in the name of their immediate relatives.
03-02-2021
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to the provisions of Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018, for the quarter ended December 31, 2020, we hereby certify that on receipt of securities for dematerialization - a. The securities comprised in the said certificate(s) of security have been listed on the stock exchanges where the earlier securities are listed; b. The said certificate(s) after due verification have been mutilated and cancelled and the name of the depositories have been substituted in the register of members as the registered owner. The above is confirmed based on the certificate received from our Registrar and Transfer Agent - Link Intime India Private Limited, which is enclosed herewith.
29-01-2021
Bigul

Fermenta Biotech Ltd - 506414 - Statement Of Investor Complaints For The Quarter Ended December 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SRIKANT SHARMADesignation :- Company Secretary and Compliance Officer
21-01-2021
Bigul

Fermenta Biotech Ltd - 506414 - Shareholding for the Period Ended December 31, 2020

 Fermenta Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
20-01-2021
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 Pursuant to the provisions of Schedule B of SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code of Conduct for Prevention of Insider Trading, regarding intimation for closure of Trading Window and further to our earlier intimation to insiders dated March 31, 2020 relating to closure of trading window from the end of every quarter for all quarters ending on June 30, September 30, December 31 and March 31, it is hereby notified that the 'Trading Window' (period for trading in Company's securities) will be closed with effect from January 1, 2021 till 48 hours after the declaration of financial results for the quarter and nine months ended December 31, 2020, as may be approved at the concerned Board Meeting.
28-12-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with a group of Investors and Analysts over audio-video conferences on Wednesday, December 23, 2020 and Thursday, December 24, 2020. This is to further inform that the 'Earnings Presentation for Quarter 2 of Financial year 2020-21' to be shared with the Investors in the above interaction, has been uploaded on the website of the Company - www.fermentabiotech.com and is also available on BSE Limited website - www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
22-12-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with a group of Investors and Analysts over audio-video conference on Thursday, December 17, 2020. This is to further inform that the 'Earnings Presentation for Quarter 2 of Financial year 2020-21' to be shared with the Investors in the above interaction, has been uploaded on the website of the Company - www.fermentabiotech.com and is also available on BSE Limited website - www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
17-12-2020
Bigul

Fermenta Biotech Ltd - 506414 - Name Change Of AGD Nutrition, LLC To Fermenta USA LLC Pursuant To Acquisition Of 52% Stake By Fermenta Biotech Limited'S US Subsidiary In AGD Nutrition, LLC

 Further to our BSE intimations dated December 03, 2020 regarding - (i) acquisition of 52% stake by Fermenta Biotech Limited's wholly owned subsidiary Fermenta Biotech USA, LLC in AGD Nutrition, LLC and (ii) Joint Press Release by Fermenta Biotech Limited and AGD Nutrition, LLC about the said acquisition, we wish to inform you that, after the said acquisition, the name of AGD Nutrition, LLC has been renamed as Fermenta USA LLC with effect from December 09, 2020. A copy of the Press Release for the above name change is enclosed for your records. This information will thereafter be uploaded on the website of the Company at www.fermentabiotech.com Kindly take the above on record.
15-12-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with a group of Investors and Analysts over audio-video conferences on Monday, December 14, 2020 and Tuesday, December 15, 2020. This is to further inform that the 'Earnings Presentation for Quarter 2 of Financial year 2020-21' to be shared with the Investors in the above interaction, has been uploaded on the website of the Company - www.fermentabiotech.com and is also available on BSE Limited website - www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
14-12-2020
Next Page
Close

Let's Open Free Demat Account